Pfizer (NYSE:PFE) Stock Price Down 0.8% on Analyst Downgrade
Pfizer Inc. (NYSE:PFE – Get Free Report)’s share price fell 0.8% during trading on Thursday after UBS Group lowered their price target on the stock from $31.00 to $29.00. UBS Group currently has a ...
Pfizer Inc. (NYSE:PFE) is largely controlled by institutional shareholders who own 68% of the company
Every investor in Pfizer Inc. ( NYSE:PFE) should be aware of the most powerful shareholder groups. We can see that ...
Pfizer: A Step-By-Step Strategy Before Earnings
PFE's strong economic moat is threatened by upcoming patent expirations, but its oncology segment shows promising growth ...
Range Financial Group LLC Acquires Shares of 13,317 Pfizer Inc. (NYSE:PFE)
Range Financial Group LLC purchased a new stake in Pfizer Inc. (NYSE:PFE – Free Report) during the fourth quarter, according ...
Pfizer Inc. stock outperforms competitors on strong trading day
Pfizer Inc. closed $4.65 short of its 52-week high ($31.54), which the company reached on July 30th.